About Company
Pro Bono Bio, an international pharmaceutical company, develops and commercializes new medicines in the Russian Federation. Its products include FLEXISEQ, a pain relieving gel containing absorbing nanostructures (Sequessomes) for the treatment of pain associated with osteoarthritis; EXOSEQ, which delivers Sequessomes to the upper dermal layers of the skin for the treatment of inflammatory conditions, such as eczema and seborrhoeic dermatitis; and ROSSOSEQ,
Pro Bono Bio, an international pharmaceutical company, develops and commercializes new medicines in the Russian Federation. Its products include FLEXISEQ, a pain relieving gel containing absorbing nanostructures (Sequessomes) for the treatment of pain associated with osteoarthritis; EXOSEQ, which delivers Sequessomes to the upper dermal layers of the skin for the treatment of inflammatory conditions, such as eczema and seborrhoeic dermatitis; and ROSSOSEQ, which distributes Sequessome vesicles into lower dermal tissues in the skin to treat psoriasis and atopic eczema conditions. The company also develops blood products, CV diagnostics, anti-infectives, and biological drugs. Pro Bono Bio was ...
